REGENXBIO Inc.
RGNX
$9.01
$0.9011.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -175.57M | -157.69M | -227.10M | -238.81M | -241.08M |
| Total Depreciation and Amortization | 15.84M | 15.99M | 16.22M | 16.53M | 16.94M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.17M | 27.56M | 32.23M | 36.92M | 36.61M |
| Change in Net Operating Assets | 41.68M | 30.10M | 5.53M | 3.10M | -3.59M |
| Cash from Operations | -87.89M | -84.04M | -173.13M | -182.26M | -191.12M |
| Capital Expenditure | -2.82M | -2.90M | -2.44M | -2.48M | -3.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.34M | 137.91M | 105.88M | 99.63M | 89.14M |
| Cash from Investing | -5.16M | 135.01M | 103.45M | 97.15M | 85.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.22M | 1.14M | 133.58M | 133.75M | 139.31M |
| Repurchase of Common Stock | -510.00K | -567.00K | -967.00K | -967.00K | -967.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 114.13M | -34.41M | -39.93M | -44.32M | -43.83M |
| Cash from Financing | 114.84M | -33.84M | 92.68M | 88.46M | 94.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.79M | 17.13M | 23.00M | 3.35M | -11.06M |